Artiva Biotherapeutics Inc (ARTV)
4.23 +0.19 (+4.70%) 11:32 ET [NASDAQ]
4.17 x 43 4.27 x 6
Realtime by (Cboe BZX)
4.17 x 43 4.27 x 6
Realtime 3.50 -0.54 (-13.37%) 07:31 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | ARTV | BMEA | KYTX | ||
| Company | Artiva Biotherapeutics Inc | Biomea Fusion Inc | Kyverna Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.02 | 2.76 | 2.24 | ||
| High | 4.75 | 2.83 | 2.38 | ||
| Low | 3.64 | 2.71 | 2.20 | ||
| Last | 4.23 | 2.80 | 2.37 | ||
| Change | +0.19 | +0.03 | +0.10 | ||
| % Change | +4.70% | +1.08% | +4.41% | ||
| Volume | 75,607 | 148,607 | 140,962 | ||
| 20-Day Average Volume | 100,013 | 636,386 | 265,372 | ||
| Previous Close | 4.04 | 2.77 | 2.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.73 | 2.72 | 2.60 | ||
| 20-Day Raw Stochastic | 32.88% | 38.10% | 15.24% | ||
| 20-Day Relative Strength | 44.81% | 39.71% | 34.06% | ||
| Weighted Alpha | -67.62 | -71.49 | -90.50 | ||
| Today's Opinion | N/A | 88% Sell | 100% Sell | ||
| Previous Opinion | N/A | 88% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.20% since 03/14/25 | +9.65% since 03/14/25 | -6.40% since 03/14/25 | ||
| Low | 3.67 on 03/21/25 | 2.40 on 03/18/25 | 2.22 on 03/21/25 | ||
| High | 5.98 on 03/17/25 | 2.84 on 03/20/25 | 2.62 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | +21.49% since 02/21/25 | -19.51% since 02/21/25 | -15.83% since 02/21/25 | ||
| Low | 3.62 on 02/28/25 | 2.35 on 03/11/25 | 2.22 on 03/21/25 | ||
| High | 6.54 on 03/12/25 | 3.50 on 02/24/25 | 3.03 on 02/26/25 | ||
| 3-Month | |||||
| %Chg | -58.78% since 12/20/24 | -34.16% since 12/20/24 | -41.50% since 12/20/24 | ||
| Low | 3.37 on 02/12/25 | 2.35 on 03/11/25 | 2.22 on 03/21/25 | ||
| High | 11.55 on 01/08/25 | 4.59 on 01/24/25 | 4.26 on 01/03/25 | ||
| 6-Month | |||||
| %Chg | -63.24% since 09/20/24 | -67.77% since 09/20/24 | -63.38% since 09/20/24 | ||
| Low | 3.37 on 02/12/25 | 2.35 on 03/11/25 | 2.22 on 03/21/25 | ||
| High | 17.31 on 10/01/24 | 13.07 on 10/09/24 | 7.20 on 12/02/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 98,128 | 100,382 | 98,000 | ||
| Shares Outstanding, K | 24,289 | 36,239 | 43,172 | ||
| Annual Sales | 33,492,000 | 0 | 0 | ||
| Annual Net Income | -27,696,000 | -117,260,000 | -60,370,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -17,840,000 | -32,790,000 | -34,490,000 | ||
| 60-Month Beta | N/A | -0.26 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.92 on 11/12/24 | -0.91 on 10/29/24 | -0.80 on 11/13/24 | ||
| Latest Earnings Date | 03/25/25 | 04/07/25 | 03/25/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||